Ann: Kazia licenses paxalisib to Simcere in Greater China, page-3

Yes very good.....makes the company look very cheap, even if this was the only market in the world.

China deals are a bonus.....note this massive milestone payment is for GBM only.

Still probably a bigger Japan deal to come.....what does USA and the west financial figure look like (billion)

China hospitals/patients in the AGILE trial so. GBM approval in China could be very soon. (VERY SOON - THE WAY CHINA OPERATES).

Well done to them. Could be $40 or $50 in States tonight.